Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Submitted by
admin
on April 7, 2014 - 12:53pm
Source:
Forbes
News Tags:
FDA
Novartis
Bexsero
vaccines
breakthrough therapies
meningitis B
Headline:
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Do Not Allow Advertisers to Use My Personal information
